Repligen
RGEN
#2045
Rank
S$12.03 B
Marketcap
S$213.80
Share price
-0.47%
Change (1 day)
12.28%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$1.08 Billion

According to Repligen 's latest financial reports the company's total liabilities are S$1.08 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.16 B1.8%
2023-12-31S$1.14 B37.46%
2022-12-31S$0.83 B1.22%
2021-12-31S$0.82 B66.32%
2020-12-31S$0.49 B7.76%
2019-12-31S$0.45 B111.17%
2018-12-31S$0.21 B6.9%
2017-12-31S$0.20 B16.89%
2016-12-31S$0.17 B423.36%
2015-12-31S$33.22 M51.84%
2014-12-31S$21.88 M17.03%
2013-12-31S$18.69 M18.67%
2012-12-31S$15.75 M
2011-03-31S$6.56 M-11.39%
2010-03-31S$7.4 M5.26%
2009-03-31S$7.03 M7.77%
2008-03-31S$6.52 M21.63%
2007-03-31S$5.36 M4.16%
2006-03-31S$5.15 M-6.34%
2005-03-31S$5.5 M34.36%
2004-03-31S$4.09 M3.36%
2003-03-31S$3.96 M-19.54%
2002-03-31S$4.92 M115.8%
2001-03-31S$2.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
S$1.73 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.63 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$141.54 B 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$67.21 B 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.45 B 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.85 B 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.72 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.10 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$5.26 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA